August 29, 2007 - The European Society of Cardiology has released new ESC Guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy. These new guidelines cover two main areas: The permanent pacing in bradyarrhythmias, syncope and other specific conditions like hypertrophic obstructive cardiomyopathy and ventricular resynchronization as an adjunct therapy in patients with heart failure. The guidelines also cover complex devices like pacemakers and cardiac synchronizers.

August 29, 2007 - Calgary Scientific Inc. Medical Group (CSIMG), a provider of advanced visualization and analysis software solutions, announced the receipt of FDA 510(k) clearance for its ResolutionMD Cardiac suite of applications, including Calcium Scoring and Coronary Artery Analysis. The move supports CSIMG’s mission to become the ease-of-use and workflow leader by delivering integrated advanced visualization solutions through PACS, HIS, RIS, EMR and practice management tools.

August 20, 2007 - Implantable cardioverter defibrillators (ICDs) in patients with heart failure cut death rates by 20 percent, but most patients never actually get a therapeutic jolt from their heart-shock implants, a new report finds.

ICDs are lifesavers for people at high risk of sudden cardiac death. But the sophisticated devices aren't without risk. Is the benefit really worth it?

August 28, 2007 - Misys Healthcare Systems and iMedica jointly announced an agreement that Misys will license iMedica’s innovative electronic health record (EHR) and practice management (PM) solutions as the foundation for a new family of physician offerings focused on small-sized practices.

Initial products, including ASP service offerings, will be announced in November 2007. The offerings will complement the existing Misys suite of solutions, including Misys Vision, Misys Tiger, Misys EMR and Misys Payerpath.

August 28, 2007 – CardiArc Inc. announced that researchers at Emory University Hospital will perform evaluations in clinical settings of the design and performance of the company’s CardiArc SPECT system, the second healthcare facility to research and provide clinical evaluations of the heart imaging system after an agreement with Cleveland Clinic was announced in June.

The testing and research is expected to yield valuable data in gaining additional knowledge of heart disease and to optimize the imaging system’s performance.

August 28, 2007 - Scivanta Medical Corp. has entered into a development agreement with Sparton Medical Systems, in which Sparton will provide Scivanta engineering and development support for the hardware component of the Hickey Cardiac Monitoring System (HCMS).

August 28, 2007 – GE Healthcare announced that it has signed an agreement with Novation for GE’s advanced radiology and cardiology image and information management technologies, which will extend technology offerings to VHA Inc. (VHA) and the University HealthSystem Consortium (UHC), two national health care alliances, and Provista member healthcare organizations.

August 28, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced the completion of enrollment of its clinical study for the use of ablation for the treatment of atrial fibrillation.

CryoCor has enrolled over 170 patients in its clinical study and will complete a 12-month follow up for each patient. Completion of enrollment of atrial fibrillation ablation trials brings the company closer to bringing its product to market for treating atrial fibrillation.

August 28, 2007 — Niceware International LLC said ICCBBA Inc. granted licensing rights to enable Niceware Healthcare to provide ISBT 128-compliant blood bag labeling software solutions that support ISBT 128-compliant data structures and bar codes.
The licensed vendor status certifies that the NiceLabel software solutions provided by Niceware Healthcare meet the ISBT 128 global standard for the identification, labeling and information processing of human blood, tissue and organ products across international borders and disparate healthcare systems.

August 28, 2007 - Human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction, according to a study published in Nature Biotechnology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now